Assyro AI

FDA Orange Book · active-ingredient family

Sulfanilamide

Sulfanilamide is approved as 1 brand and 1 generic application in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:AVC · NDA 006530

1

Brand (NDA)

1

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · cream, suppository

ProductApplicantApplicationTEApproved
AVCRLD×2PHARMOBEDIENTNDA 006530Jan 27, 1987

Generic (ANDA) products (1)

ProductApplicantApplicationTEApproved
SULFANILAMIDECOSETTEANDA 088718Sep 19, 1985

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Sulfanilamide — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.